Administration on Intellectual and Developmental Disabilities, President's Committee for People With Intellectual Disabilities Meeting, 4627-4628 [2016-01586]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 17 / Wednesday, January 27, 2016 / Notices
4627
FEDERAL MARITIME COMMISSION
Include in the email subject line
‘‘Petition No P1–16.’’
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Petition No. P1–16]
Karen V. Gregory,
Secretary.
Administration for Community Living
[FR Doc. 2016–01579 Filed 1–26–16; 8:45 am]
Administration on Intellectual and
Developmental Disabilities, President’s
Committee for People With Intellectual
Disabilities Meeting
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Petition of COSCO Container Lines
Company Limited for an Exemption
From Commission Regulations; Notice
of Filing and Request for Comments
This is to provide notice of filing and
to invite comments on or before
February 12, 2016, with regard to the
Petition described below.
COSCO Container Lines Company
Limited (‘‘COSCON’’) (Petitioner), has
petitioned the Commission pursuant to
46 CFR 502.76 of the Commission’s
Rules of Practice and Procedure, for an
exemption from the Commission’s rules
requiring individual service contract
amendments, 46 CFR 530.10.
Specifically, Petitioner explains that
‘‘[o]n or about March 1, 2016, COSCON
will acquire by time charter the
containerships and certain other assets
of China Shipping Container Lines Co.
(‘‘China Shipping’’)’’ and, as such,
requests that the Commission permit the
submission of a ‘‘universal notice to the
Commission and to the service contract
parties’’ instead of filing an amendment
for each of the seven hundred (700)
service contracts that will be assigned to
COSCON. In addition COSCON
proposes to send electronic notice to
each shipper counter party. Because
China Shipping tariffs will be taken over
by COSCON and renumbered and
republished, COSCON also seeks a
waiver to avoid amending each contract
with the new tariff number, by
publishing a notice of the change in the
existing China Shipping and COSCON
tariffs.
The Petition in its entirety is posted
on the Commission’s Web site at
https://www.fmc.gov/p1-16. Comments
filed in response to this Petition will be
posted on the Commission’s Web site at
this location.
In order for the Commission to make
a thorough evaluation of the Petition,
interested persons are requested to
submit views or arguments in reply to
the Petition no later than February 12,
2016. Commenters must send an
original and 5 copies to the Secretary,
Federal Maritime Commission, 800
North Capitol Street NW., Washington,
DC 20573–0001, and be served on
Petitioner’s counsel, Robert B.
Yoshitomi, or Eric C. Jeffrey, Nixon
Peabody LLP, 799 9th Street NW.,
Washington, DC 20001. A PDF copy of
the reply must also be sent as an
attachment to Secretary@fmc.gov.
VerDate Sep<11>2014
19:41 Jan 26, 2016
Jkt 238001
BILLING CODE 6731–AA–P
FEDERAL RESERVE SYSTEM
Notice of Proposals To Engage in or
To Acquire Companies Engaged in
Permissible Nonbanking Activities
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y, (12
CFR part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act.
The comment period for this notice
has been extended. Comments regarding
the notice must be received at the
Reserve Bank indicated or the offices of
the Board of Governors not later than
February 16, 2016.
A. Federal Reserve Bank of New York
(Ivan Hurwitz, Vice President) 33
Liberty Street, New York, New York
10045–0001:
1. New York Community Bancorp,
Inc. Westbury, New York; to acquire 100
percent of the voting shares of Astoria
Financial Corporation, Lake Success,
New York, and indirectly acquire
Astoria Bank, Long Island City, New
York, and thereby engage in extending
credit and services loans, and in
operating a saving association, pursuant
to § 225.28(b)(1) and (b)(4)(ii).
Board of Governors of the Federal Reserve
System, January 21, 2016.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2016–01546 Filed 1–26–16; 8:45 am]
BILLING CODE 6210–01–P
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
Monday, February 22, 2016 from
9:00 a.m. to 4:30 p.m.; and Tuesday,
February 23, 2016 from 9:00 a.m. to 2:00
p.m.
These meetings will be open to the
general public.
ADDRESSES: These meetings will be held
in the U.S. Department of Health and
Human Services/Hubert H. Humphrey
Building located at 200 Independence
Avenue SW., Conference Room 800,
Washington, DC 20201.
Individuals who would like to
participate via conference call may do
so by dialing toll-free #: 888–469–0957,
when prompted enter pass code:
8955387. Individuals whose full
participation in the meeting will require
special accommodations (e.g., sign
language interpreting services, assistive
listening devices, materials in
alternative format such as large print or
Braille) should notify Dr. MJ Karimi,
PCPID Team Lead, via email at
MJ.Karimie@acl.hhs.gov, or via
telephone at 202–795–7374, no later
than Tuesday, February 16, 2016. The
PCPID will attempt to accommodate
requests made after this date, but cannot
guarantee the ability to grant requests
received after the deadline. All meeting
sites are barrier free, consistent with the
Americans with Disabilities Act (ADA)
and the Federal Advisory Committee
Act (FACA).
FOR FURTHER INFORMATION CONTACT: For
further information, please contact Dr.
MJ Karimi, Team Lead, President’s
Committee for People with Intellectual
Disabilities, 330 C Street SW., 1108 A,
Washington, DC 20201. Telephone:
202–795–7374. Fax: 202–205–0402.
Email: MJ.Karimie@acl.hhs.gov.
SUPPLEMENTARY INFORMATION: The
PCPID acts in an advisory capacity to
the President and the Secretary of
Health and Human Services on a broad
range of topics relating to programs,
services and support for individuals
with intellectual disabilities. The PCPID
executive order stipulates that the
Committee shall: (1) Provide such
advice concerning intellectual
disabilities as the President or the
Secretary of Health and Human Services
DATES:
E:\FR\FM\27JAN1.SGM
27JAN1
4628
Federal Register / Vol. 81, No. 17 / Wednesday, January 27, 2016 / Notices
may request; and (2) provide advice to
the President concerning the following
for people with intellectual disabilities:
(A) Expansion of educational
opportunities; (B) promotion of
homeownership; (C) assurance of
workplace integration; (D) improvement
of transportation options; (E) expansion
of full access to community living; and
(F) increasing access to assistive and
universally designed technologies.
Agenda: The Committee Members
will discuss preparation of the PCPID
2016 Report to the President, including
its contents and format, and related data
collection and analysis required to
complete the writing of the Report in
the following focus areas:
Family engagement early on in the
process to support high expectations for
students with disabilities.
Federal policies and enforcement
strategies to end segregation in schools
and other aspects of community living
beyond graduation.
Transition as a critical area for
pathways to higher education and career
development.
Self-determination/Supported
decision-making from early childhood
throughout the individual’s lifespan.
Dated: January 14, 2016.
Aaron Bishop,
Commissioner, Administration on
Disabilities.
[FR Doc. 2016–01586 Filed 1–26–16; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0559]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Public Health
Service Guideline on Infectious
Disease Issues in Xenotransplantation
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by February
26, 2016.
ADDRESSES: To ensure that comments on
the information collection are received,
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:41 Jan 26, 2016
Jkt 238001
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0456. Also
include the FDA docket number found
in brackets in the heading of this
document.
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
PHS Guideline on Infectious Disease
Issues in Xenotransplantation
OMB Control Number 0910–0456—
Extension
The statutory authority to collect this
information is provided under sections
351 and 361 of the PHS Act (42 U.S.C.
262 and 264) and the provisions of the
Federal Food, Drug, and Cosmetic Act
that apply to drugs (21 U.S.C. 301 et
seq.). The PHS guideline recommends
procedures to diminish the risk of
transmission of infectious agents to the
xenotransplantation product recipient
and to the general public. The PHS
guideline is intended to address public
health issues raised by
xenotransplantation, through
identification of general principles of
prevention and control of infectious
diseases associated with
xenotransplantation that may pose a
hazard to the public health. The
collection of information described in
this guideline is intended to provide
general guidance on the following
topics: (1) The development of
xenotransplantation clinical protocols;
(2) the preparation of submissions to
FDA; and (3) the conduct of
xenotransplantation clinical trials. Also,
the collection of information will help
ensure that the sponsor maintains
important information in a crossreferenced system that links the relevant
records of the xenotransplantation
product recipient, xenotransplantation
product, source animal(s), animal
procurement center, and significant
nosocomial exposures. The PHS
guideline describes an occupational
health service program for the
protection of health care workers
involved in xenotransplantation
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
procedures, caring for
xenotransplantation product recipients,
and performing associated laboratory
testing. The PHS guideline is intended
to protect the public health and to help
ensure the safety of using
xenotransplantation products in
humans by preventing the introduction,
transmission, and spread of infectious
diseases associated with
xenotransplantation.
The PHS guideline also recommends
that certain specimens and records be
maintained for 50 years beyond the date
of the xenotransplantation. These
include: (1) Records linking each
xenotransplantation product recipient
with relevant health records of the
source animal, herd or colony, and the
specific organ, tissue, or cell type
included in or used in the manufacture
of the product (section 3.2.7.1); (2)
aliquots of serum samples from
randomly selected animal and specific
disease investigations (section 3.4.3.1);
(3) source animal biological specimens
designated for PHS use (section 3.7.1);
animal health records (section 3.7.2),
including necropsy results (section
3.6.4); and (4) recipients’ biological
specimens (section 4.1.2). The retention
period is intended to assist health care
practitioners and officials in
surveillance and in tracking the source
of an infection, disease, or illness that
might emerge in the recipient, the
source animal, or the animal herd or
colony after a xenotransplantation.
The recommendation for maintaining
records for 50 years is based on clinical
experience with several human viruses
that have presented problems in human
to human transplantation and are
therefore thought to share certain
characteristics with viruses that may
pose potential risks in
xenotransplantation. These
characteristics include long latency
periods and the ability to establish
persistent infections. Several also share
the possibility of transmission among
individuals through intimate contact
with human body fluids. Human
immunodeficiency virus (HIV) and
human T-lymphotropic virus are human
retroviruses. Retroviruses contain
ribonucleic acid that is reversetranscribed into deoxyribonucleic acid
(DNA) using an enzyme provided by the
virus and the human cell machinery.
That viral DNA can then be integrated
into the human cellular DNA. Both
viruses establish persistent infections
and have long latency periods before the
onset of disease; 10 years and 40 to 60
years, respectively. The human hepatitis
viruses are not retroviruses, but several
share with HIV the characteristic that
they can be transmitted through body
E:\FR\FM\27JAN1.SGM
27JAN1
]]>Agencies
[Federal Register Volume 81, Number 17 (Wednesday, January 27, 2016)]
[Notices]
[Pages 4627-4628]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-01586]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living
Administration on Intellectual and Developmental Disabilities,
President's Committee for People With Intellectual Disabilities Meeting
AGENCY: Administration for Community Living, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
DATES: Monday, February 22, 2016 from 9:00 a.m. to 4:30 p.m.; and
Tuesday, February 23, 2016 from 9:00 a.m. to 2:00 p.m.
These meetings will be open to the general public.
ADDRESSES: These meetings will be held in the U.S. Department of Health
and Human Services/Hubert H. Humphrey Building located at 200
Independence Avenue SW., Conference Room 800, Washington, DC 20201.
Individuals who would like to participate via conference call may
do so by dialing toll-free #: 888-469-0957, when prompted enter pass
code: 8955387. Individuals whose full participation in the meeting will
require special accommodations (e.g., sign language interpreting
services, assistive listening devices, materials in alternative format
such as large print or Braille) should notify Dr. MJ Karimi, PCPID Team
Lead, via email at MJ.Karimie@acl.hhs.gov, or via telephone at 202-795-
7374, no later than Tuesday, February 16, 2016. The PCPID will attempt
to accommodate requests made after this date, but cannot guarantee the
ability to grant requests received after the deadline. All meeting
sites are barrier free, consistent with the Americans with Disabilities
Act (ADA) and the Federal Advisory Committee Act (FACA).
FOR FURTHER INFORMATION CONTACT: For further information, please
contact Dr. MJ Karimi, Team Lead, President's Committee for People with
Intellectual Disabilities, 330 C Street SW., 1108 A, Washington, DC
20201. Telephone: 202-795-7374. Fax: 202-205-0402. Email:
MJ.Karimie@acl.hhs.gov.
SUPPLEMENTARY INFORMATION: The PCPID acts in an advisory capacity to
the President and the Secretary of Health and Human Services on a broad
range of topics relating to programs, services and support for
individuals with intellectual disabilities. The PCPID executive order
stipulates that the Committee shall: (1) Provide such advice concerning
intellectual disabilities as the President or the Secretary of Health
and Human Services
[[Page 4628]]
may request; and (2) provide advice to the President concerning the
following for people with intellectual disabilities: (A) Expansion of
educational opportunities; (B) promotion of homeownership; (C)
assurance of workplace integration; (D) improvement of transportation
options; (E) expansion of full access to community living; and (F)
increasing access to assistive and universally designed technologies.
Agenda: The Committee Members will discuss preparation of the PCPID
2016 Report to the President, including its contents and format, and
related data collection and analysis required to complete the writing
of the Report in the following focus areas:
Family engagement early on in the process to support high
expectations for students with disabilities.
Federal policies and enforcement strategies to end segregation in
schools and other aspects of community living beyond graduation.
Transition as a critical area for pathways to higher education and
career development.
Self-determination/Supported decision-making from early childhood
throughout the individual's lifespan.
Dated: January 14, 2016.
Aaron Bishop,
Commissioner, Administration on Disabilities.
[FR Doc. 2016-01586 Filed 1-26-16; 8:45 am]
BILLING CODE 4154-01-P
